Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

Abstract The prevalence of multiple sexual partners (MSPs) remains high worldwide, with sub-Saharan Africa reporting some of ...

Federal National Mortgage Association (FNMA) drew attention as it delivered its third quarter earnings report, revealing a decrease in net income from a year earlier. At the same time, a senior ...

Hyatt’s technicals maintain its bullish signals after rebounding from its most recent low of $134. It now trades above the 50 ...

Existing frameworks like the U.S. Environmental Protection Agency’s Energy Star Portfolio Manager provide useful performance ...

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven by ...

While self-healing agentic test suites can help eliminate the manual intervention consuming engineering cycles, there are key ...

Scientists used drones to sample the breath of whales and showed that the microbes in that breath track the animals’ health.

Monoclonal antibody (mAb) manufacturing must continually improve to keep up with increasing demands. To do this, biomanufacturers can deploy machine learning tools to augment traditional process ...

Introduction Perinatal depression in low- and middle-income countries is a global health concern. Interventions to support ...

Millions of Americans with anxiety and depression struggle to find the right medication. The best fit may depend on your ...

Toyota Industries (TSE:6201) caught investors’ attention after its recent board meeting, where the company cut its full-year earnings guidance and suspended the interim dividend for fiscal 2026. Both ...